• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Mind the gap: What is causing the ongoing ADHD drug shortage?

cafead

Administrator
Staff member
  • cafead   Jun 07, 2024 at 11:32: AM
via Since late 2022, medications for Attention Deficit/Hyperactivity Disorder, or ADHD, have been in a shortage in the United States and the UK. What began as a paucity of long acting medications, specifically Adderall in the US and Methylphenidate prolonged-release capsules in the UK, has snowballed into an ongoing shortage of nearly every ADHD medication as patients scramble to access prescriptions they can fill.

article source